Barclays
AXLA

Barclays’s Axcella Health Inc. Common Stock AXLA Stock Holding History

Barclays’s Portfolio AXLA Stock Details AXLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-93
Closed -$7K – 4867
2021
Q3 		$7K Sell
93
-34
-27% -$2.91K ﹤0.01% 4582
2021
Q2 		$13K Sell
127
-391
-75% -$38.8K ﹤0.01% 4585
2021
Q1 		$62K Buy
518
+318
+159% +$44.9K ﹤0.01% 4162
2020
Q4 		$26K Sell
200
-73
-27% -$9.38K ﹤0.01% 4626
2020
Q3 		$31K Buy
273
+60
+28% +$7.39K ﹤0.01% 4792
2020
Q2 		$30K Buy
213
+108
+103% +$13.2K ﹤0.01% 5115
2020
Q1 		$9K Sell
105
-207
-66% -$21.2K ﹤0.01% 5856
2019
Q4 		$31K Buy
312
+254
+438% +$27.9K ﹤0.01% 5885
2019
Q3 		$9K Sell
58
-210
-78% -$38.9K ﹤0.01% 6385
2019
Q2 		$62K Buy
+268
New +$84.9K ﹤0.01% 5994

Other funds holding AXLA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barclays's AXLA Position: Q4 2021 in Review

Barclays sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2021, closing a stake of 93 shares — an estimated $7K sold.

Barclays first reported a position in AXLA in Q2 2019 and held it in 10 quarters. The position peaked at $62K in Q1 2021. 35 funds tracked by Wall St. Rank hold AXLA as of Q4 2021.

  • Barclays reported no remaining Axcella Health Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Barclays sold 93 Axcella Health Inc. Common Stock shares in Q4 2021, an estimated $7K.
  • Barclays first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 10 quarters.
  • Barclays's Axcella Health Inc. Common Stock position peaked at $62K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2021.

Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.